1. Home
  2. CRI vs SANA Comparison

CRI vs SANA Comparison

Compare CRI & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$31.54

Market Cap

1.0B

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$4.14

Market Cap

983.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
SANA
Founded
1865
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
983.4M
IPO Year
2003
2021

Fundamental Metrics

Financial Performance
Metric
CRI
SANA
Price
$31.54
$4.14
Analyst Decision
Sell
Strong Buy
Analyst Count
4
7
Target Price
$29.50
$7.83
AVG Volume (30 Days)
986.0K
4.2M
Earning Date
10-27-2025
11-06-2025
Dividend Yield
3.17%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$2,832,687,000.00
N/A
Revenue This Year
$1.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.38
$1.26
52 Week High
$58.13
$7.30

Technical Indicators

Market Signals
Indicator
CRI
SANA
Relative Strength Index (RSI) 53.15 51.85
Support Level $31.00 $3.93
Resistance Level $32.44 $4.35
Average True Range (ATR) 1.34 0.36
MACD 0.06 0.07
Stochastic Oscillator 61.26 81.09

Price Performance

Historical Comparison
CRI
SANA

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: